| Structure | Chemical Name | CAS | MF |
|
(+)-N-[(S)-α-Cyanobenzyl]acetamide
|
|
|
|
|
N-[[(3S)-6-Cyano-3,4-dihydro-3β-hydroxy-2,2-dimethyl-2H-1-benzopyran]-4-yl]carbamic acid ethyl ester
|
|
|
|
Boc-L-Val-nitrile
|
216319-90-3
|
C10H18N2O2
|
|
(+)-N-[(S)-1-Cyclohexylethyl]phthalimide
|
|
C16H19NO2
|
|
N-[(1S)-1-[[[Cyclopentyl][[[1-(trifluoroacetyl)-2-methylpropyl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
|
|
C32H38ClF3N4O7S
|
|
(+)-N-[(S)-2-Cyclohexyl-1-methylethyl]-2-methylenesuccinimide
|
|
C14H21NO2
|
|
(+)-N-[(S)-2-Cyclohexyl-1-methylethyl]maleimide
|
|
C13H19NO2
|
|
(-)-N-[(S)-1-Cyclohexyl-2-(acetyloxy)ethyl]benzamide
|
|
C17H23NO3
|
|
(+)-N-[(S)-1-Cyclohexyl-2-benzoyloxyethyl]dibenzoylamine
|
|
C29H29NO4
|
|
(-)-N-[(S)-1-Cyclohexyl-2-acetyloxyethyl]acetamide
|
|
C12H21NO3
|
|
(-)-N-[(S)-1-Cyclohexylethyl]-2-methylenesuccinimide
|
|
C13H19NO2
|
|
N-[(1S)-1-[[[Cyclooctyl][[[1-(trifluoroacetyl)-2-methylpropyl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
|
|
C35H44ClF3N4O7S
|
|
N-[(1S)-1-Cyclohexylethyl]maleimide
|
|
C12H17NO2
|
|
(-)-N-[(S)-1-Cyclohexyl-2-hydroxyethyl]benzamide
|
|
C15H21NO2
|
|
(+)-N-[(S)-2-Cyclohexyl-1-methylethyl]benzamide
|
|
C16H23NO
|
|
(+)-N-[(S)-1-Cyclohexylethyl]benzamide
|
|
C15H21NO
|
|
(-)-N-[(S)-1-Cyclohexylethyl]acetamide
|
|
C10H19NO
|
|
(-)-N-[(S)-1-Cyclohexyl-2-hydroxyethyl]acetamide
|
|
C10H19NO2
|
|
N-[(S)-2-[[[(Dodecanoyl)amino]acetyl]amino]-5-methylhexanoyl]-L-valine methyl ester
|
|
C27H51N3O5
|
|
|
N-[[(2S)-1-Dodecylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
|
nRNP
|
|
|
|
|
N-[[(2R)-1-Nonylpyrrolidin-2β-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
|
NSE, Gamma-Enolase
|
|
|
|
|
NSD3 protein
|
|
|
|
|
NSD1 protein
|
|
|
|
|
(+)-N-[(R)-p-Amino-α-methylbenzyl]phthalimide
|
|
|
|
|
NSF Antibody
|
|
|
|
|
NSF Antibody 1
|
|
|
|
|
(+)-N-[(R)-p-Bromo-α-methylbenzyl]phthalimide
|
|
|
|
|
NSE Mouse Monoclonal
|
|
|
|
|
NSE (Neuron specific Enolase)
|
|
|
|
NRPE
|
30576-47-7
|
C57H100NO8P
|
|
|
(+)-N-[2-[[(R)-1-O,2-O-Dipalmitoyl-L-glycero-3-phospho]oxy]ethyl]phthalimide
|
|
|
|
|
(+)-N-[2-[[(R)-1-O,2-O-Dimyristoyl-L-glycero-3-phospho]oxy]ethyl]acetamide
|
|
|
|
|
(-)-N-[2-[(R)-1-O,2-O-Dioctadecyl-L-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
|
(+)-N-[2-[(R)-1-O,2-O-Dimyristoyl-L-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
|
(+)-N-[2-[(R)-1-O,2-O-Dipalmitoyl-L-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
|
(-)-N-[2-[(R)-1-O,2-O-Dihexadecyl-L-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
N-[(R)-1-(Pentachlorophenyl)-2-methyl-2-propenyl]-4-methylbenzenesulfonamide
|
|
C17H14Cl5NO2S
|
|
|
NSEP-1 protein
|
|
|
|
|
N4SE protocol
|
|
|
|
N-((R)-1-phenylethyl)quinuclidin-3-aMine (dihydrochloride)
|
|
C15H24Cl2N2
|
|
N-[(1R)-1-PHENYLETHYL]-8-THIEN-3-YL-1,6-NAPHTHYRIDINE-2-CARBOXAMIDE
|
|
C21H17N3OS
|
|
N-[(R)-(+)-1-PHENYLETHYL]IMIDAZOLE-1-CARBOXAMIDE
|
1217846-28-0
|
C12H13N3O
|
|
N-[(1R)-1-Phenylethyl]-1-phenylethylideneamine
|
|
C16H17N
|
|
N-[(R)-1-Phenyl-2-hydroxyethyl]benzamide
|
|
C15H15NO2
|
|
N-[(R)-1-Phenylheptan-3-yl]acetamide
|
|
C15H23NO
|
|
N-[(1R)-1-Phenylethyl]-4-methylbenzenesulfonamide
|
|
C15H17NO2S
|
|
N-[(1R)-1-Phenyl-2-chloroethyl]benzamide
|
|
C15H14ClNO
|
|
|
(-)-N-[(R)-α-Phenacylbenzyl]benzamide
|
|
|
|
N-[(R)-4-Phenylbutan-2-yl]carbamic acid methyl ester
|
|
C12H17NO2
|
|
N-[(1R)-1-Phenylethyl](2-pyridyl)methanimine
|
|
C14H14N2
|
|
(-)-N-[(R)-1-(4-Phenyl-2-thiazolyl)ethyl]benzamide
|
|
C18H16N2OS
|
|
|
(-)-N-[(R)-α-Phenylphenacyl]formamide
|
|
|
|
N-[(R)-1-Phenylbutan-2-yl]adenosine
|
|
C20H25N5O4
|
|
N-[(R)-1-Phenylheptan-3-yl]carbamic acid methyl ester
|
|
C15H23NO2
|
|
N-[(R)-1-Phenylethyl]carbamic acid (E)-3-cyclohexylallyl ester
|
|
C18H25NO2
|
|
N-Serinyl-S-acetylcysteamine trifluoroacetate
|
147529-77-9
|
|
|
|
N-26 SEQUENCING PRIMER
|
|
|
|
N3-Ser(OtBu)-OH CHA salt
|
1228077-87-9
|
C13H26N4O3
|
|
|
NR1, phosphorylated (Ser897) (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
|
NR1, phosphorylated, Antibody Kit, BioAssay (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
|
NR1, phosphorylated (Ser896) (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
N-[(2S,3E,5S)-2-Isopropyl-5-[(tert-butoxycarbonyl)amino]-1-oxo-3-hexenyl]-L-phenylalanine methyl ester
|
|
C24H36N2O5
|
|
(-)-N-[(R)-4-Phthalimidyl-2-(p-tolylsulfonylamino)butyryl]glycine ethyl ester
|
|
C23H25N3O7S
|
|
N-[1-(S)-ERTHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANINE
|
|
C15H21NO4
|
|
|
Nse2 (Smc5-6)
|
|
|
|
N-Seryl-N'-(2,3,4-trihydroxybenzyl)hydrazine
|
26652-10-8
|
C10H15N3O5
|
|
|
(+)-N-[(R)-p-Iodo-α-methylbenzyl]phthalimide
|
|
|
|
N-[(3R)-3-PIPERIDINYLMETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER
|
879275-33-9
|
C11H22N2O2
|
|
|
N-[[(2R)-Piperidin-2-yl]carbonyl]-L-Leu-Gly-NH2
|
|
|
|
(-)-N-[(S)-1-Ethylpentyl]acetamide
|
|
C9H19NO
|
|
|
(-)-N2-[(S)-α-Ethyl-α-methylbenzyl]-p-toluenesulfonohydrazide
|
|
|
|
N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine
|
82834-12-6
|
C10H19NO4
|
|
Ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate
|
84793-24-8
|
C16H19NO5
|
|
N-(4-([[(1S)-1-(ETHOXYCARBONYL)-3-METHYLBUTYL](METHYL)AMINO]SULFONYL)BENZYL)-3-NITRO-4-PYRIDINAMINIUM CHLORIDE
|
1030603-71-4
|
C21H29ClN4O6S
|
|
N-[[(2S)-1-Ethylpyrrolidine-2-yl]methyl]-2-methoxy-3-bromo-5-ethyl-6-hydroxybenzamide
|
|
C17H25BrN2O3
|
|
N-[(1S)-1-((Ethoxycarbonylmethyl)carbamoyl)isobutyl]-N-(trifluoroacetyl)glycinamide
|
|
C13H20F3N3O5
|
|
|
N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-Ala-N2-benzyl-N6-(4-ethoxycarbonyl-2-aminosulfonyl-5-chlorophenyl)-L-Lys-OH
|
|
|
|
(+)-N-[(S)-1-Ethylheptyl]benzamide
|
|
C16H25NO
|
|
(-)-N-[[(2S)-1-Ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-3-iodo-6-methoxybenzamide
|
113716-48-6
|
C15H21IN2O3
|
|
|
N-[1-[(S)-9-Ethoxy-6-oxylato-6-oxo-5,7,11-trioxa-6-phospha(V)heptacosan-1-yl]pyridin-4(1H)-ylidene]-N-methylmethanaminium
|
|
|
|
(+)-N-[(S)-2-Ethyl-3-methylbutyryl]-4-morpholinecarbothioamide
|
|
C12H22N2O2S
|
|
|
(-)-N-[(S)-α-Ethyl-α-methylbenzyl]benzenesulfonamide
|
|
|
|
N-[[(2S)-1-Ethylpyrrolidine-2-yl]methyl]-2-methoxy-3-bromo-6-hydroxybenzamide
|
96393-00-9
|
C15H21BrN2O3
|
|
|
N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-Ala-N6-(3-aminosulfonyl-4-chlorobenzoyl)-N2-[(2,3-dihydro-1H-inden)-2-yl]-L-Lys-OH
|
|
|
|
(-)-N-[(S)-1-(Ethoxycarbonyl)-3-(p-nitrophenyl)propyl]phthalamidic acid
|
|
C21H21N3O8
|
|
|
(+)-N-[(S)-α-Ethyl-α-methylbenzyl]-4-nitrobenzamide
|
|
|
|
(+)-N-[(S)-1-Ethylpentyl]benzamide
|
|
C14H21NO
|
|
|
N-[((2S)-1-Ethyl-2-pyrrolidinyl)methyl]-5-(125I)iodo-2-methoxybenzamide
|
115655-33-9
|
|
|
(-)-N-[[(2S)-1-Ethyl-2-pyrrolidinyl]methyl]-4-methoxy-2-methyl-5-pyrimidinecarboxamide
|
|
C14H22N4O2
|
|
N-[[(2S)-1-Ethylpyrrolidine-2-yl]methyl]-2,5-dimethoxy-3-bromo-6-hydroxybenzamide
|
|
C16H23BrN2O4
|
|
|
N-[(S)-α-Ethylbenzyl]benzenemethanimine
|
|
|
|
|
N-[(S)-α-Ethyl-α-methylbenzyl]acetamide
|
|
|
|
|
(-)-N-[(S)-4-Ethyl-α-methylbenzyl]benzamide
|
|
|
|
N-[4-[(1S)-4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide
|
|
C20H36N2O3S
|
|
N2-[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]-N6-(trifluoroacetyl)-L-lysine
|
|
C20H27F3N2O5
|
|
N-[[(2S)-1-Ethylpyrrolidin-2-yl]methyl]-5-(3-fluoropropyl)-2,3-dimethoxybenzamide
|
|
C19H29FN2O3
|
|
|
N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-Ala-N-[(S)-1-[(7-aminosulfonyl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide)-2-yl]-3-methylbutyl]-Gly-OH ester
|
|
|
|
|
N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-Ala-N-(5-tert-butyl-2-hydroxy-3-iodobenzyl)Gly-OH
|
|
|